Sex Differences Among Adult Influenza Hospitalizations Associated With Age, Race, And Socioeconomic Status In 14 Us Sites, 2010-2012 by Kline, Kelly Elizabeth
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Public Health Theses School of Public Health
January 2015
Sex Differences Among Adult Influenza
Hospitalizations Associated With Age, Race, And
Socioeconomic Status In 14 Us Sites, 2010-2012
Kelly Elizabeth Kline
Yale University, kellykline.epi@gmail.com
Follow this and additional works at: http://elischolar.library.yale.edu/ysphtdl
This Open Access Thesis is brought to you for free and open access by the School of Public Health at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Public Health Theses by an authorized administrator of EliScholar – A Digital Platform for
Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Kline, Kelly Elizabeth, "Sex Differences Among Adult Influenza Hospitalizations Associated With Age, Race, And Socioeconomic











Sex differences among adult influenza hospitalizations associated with age, race, and socioeconomic 
status in 14 US Sites, 2010-2012 
 
 
Kelly Kline, James L. Hadler, Linda Niccolai 
Author affiliations: Connecticut Emerging Infections Program, Yale School of Public Health, New 







BACKGROUND: Previous studies have shown sex differences in influenza hospitalizations, but sex 
differences across the United States by demographic characteristics have not been well-established. 
We investigated potential sex differences across 14 FluSurv-NET (FSN) sites that conduct active 
population-based surveillance for laboratory-confirmed influenza-associated hospitalizations among 
residents of 76 counties in 2010-2012, stratifying by age, race, and census tract-level poverty.  
METHODS: We used 6,292 laboratory-confirmed adult (>18 years) cases collected by the 14 FSN 
sites during the 2010-11 and 2011-12 influenza seasons linked to 2010 Census data to calculate 
overall age-adjusted and age-specific incidence and incidence rate ratios (IRRs) for sex by four 
race/ethnic and four census-tract poverty (SES) categories. Analyses were repeated excluding 
pregnant women, with denominator pregnancy adjustments calculated by subtracting the percentage 
of women 18-49 years old with live births in 2010. 
RESULTS: Overall, 55.5% of cases were female. Females were more likely to be hospitalized than 
males (IRR 1.17, 95% CI 1.11-1.22), but this difference did not remain after age adjustment. Females 
at highest risk were 18-49 years old (IRR 1.32, 95% 1.20-1.44), which was fully accounted for by 
pregnancy. Females were at lower risk in the ≥85 year old category (IRR 0.67, 95% CI 0.59-0.77). 
IRRs varied by race and SES, but in no SES group was the aIRR significantly greater than 1. White 
females were less likely to be hospitalized than white males (aIRR 0.91, 95% CI 0.85-0.98) while 
Hispanic females were more likely to be hospitalized than Hispanic males (aIRR 1.25, 95% CI 1.06-
1.44). Of the 14 sites examined, 12 had crude incidence rate ratios greater than 1, but none were 
significant after age adjustment.  
CONCLUSIONS: In 2010-2012, there were sex differences in influenza-associated hospitalizations 
that were highly dependent upon age, but varied by race/ethnicity and US site. Further research is 
needed to understand the drivers behind these differences, and analysis of data from different years is 
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Previous studies have identified sex differences in influenza morbidity and mortality, 
although the direction of the disparities varies by geographic location and influenza season. Overall it 
appears that influenza morbidity and mortality are higher for females (1), although numerous studies 
both in the United States and elsewhere have found the opposite effect (2, 3). A previous study from 
the Emerging Infections Program found that adult females in New Haven County, CT were more 
likely to have influenza-associated hospitalizations than males (4). This finding was most prominent 
among women of low census tract-level socioeconomic status (SES), blacks, and Hispanics, and 
could not be explained by pregnancy, vaccination, or underlying co-morbidities.  
Few studies have comprehensively assessed sex disparities in influenza morbidity and 
mortality, especially controlling for the interaction between sex and age. Two studies previously 
assessed the effects of sex, age, and census tract socioeconomic status (SES) on hospitalization rates 
in adults and children in New Haven County, Connecticut (4, 5). They found that among adults over 
a 7-year period, female sex and lower census tract-level SES were independently associated with 
higher rates of hospitalization, even when controlling for pregnancy. However, no studies have 
comprehensively examined these factors across a large geographic area to determine whether these 
findings can be applied more broadly.  
There are several hypotheses explaining sex disparities in influenza-associated 
hospitalization rates. Notably, growing evidence supports the role of biological factors that make 
females more susceptible to influenza (6). The major hypothesis for these biological mechanisms is 
that sex steroids influence the immune system and cause excessive proinflammatory cytokine and 
chemokine responses. Other, non-biological hypotheses for explaining sex disparities include 
differences in healthcare-seeking behaviors between sexes and differences in exposure to the 
influenza virus, both occupationally and from exposure to young children (1). 
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Using population-based surveillance data from 14 FluSurv-NET (FSN) sites that measure 
laboratory-confirmed influenza-associated hospitalizations among residents of 76 counties, we 
investigated potential sex disparities in influenza-associated hospitalizations by age, race, and census 







Analyses exploring sex disparities in influenza hospitalization rates were performed using 
population-based surveillance for laboratory-confirmed, influenza-associated hospitalizations from 
the 2010-2011 and 2011-2012 influenza seasons collected at 14 FSN sites across the United States. 
Residential catchment areas included the 76 counties in California, Colorado, Connecticut, Georgia, 
Maryland, Michigan, Minnesota, New Mexico, New York, Ohio, Oregon, Rhode Island, Tennessee, 
and Utah that participated in active surveillance during the study period. The total catchment 
population contained nearly 21 million adults.  
The surveillance data included the 7,936 cases collected by active surveillance that were 
successfully geocoded (of 8,716 cases, 91%), of whom 6,292 were adults. Surveillance was 
conducted by reviewing medical charts and interviewing healthcare providers and patients to 
complete a standardized case report form. Variables collected included demographic information 
(including age, sex, and race/ethnicity), residential address, co-morbidities complicating influenza, 
ICU admission, patient outcome, and vaccination status. Case residential addresses were geocoded 
by each site using a variety of methods.  
Census Data 
Overall and group-specific population estimates for the residential catchment areas were 
obtained from the 2010 Census and used for the denominator in all incidence calculations. 
Neighborhood SES data was obtained from the US Census 2010. Analyses of SES used 2008-2012 
American Community Survey (ACS) data and used the following categories describing the 
percentage of households living below the federal poverty level in each census tract: <5%, 5-<10%, 
10-<20%, and ≥20%, as recommended by the Public Health Disparities Geocoding Project (7, 10).  
Census tract-level poverty has been used in previous studies as a measure of area-based SES 
(4, 5, 11). This has been demonstrated to be an appropriate predictor of health, as a person’s health 
9 
 
may be directly influenced by the neighborhood in which he or she resides (12). In these previous 
studies, cases’ residential addresses were geocoded to census tracts in order to calculate overall and 
age-specific rates by neighborhood SES.  
Data Analysis 
All statistical analyses were performed using SAS version 9.3 (SAS Institute Inc, Cary, NC, 
USA). Average annual incidence rates were calculated by dividing the total number of cases by the 
total number of adults in the residential catchment area and dividing by two to average across two flu 
seasons. Incidence rate ratios were calculated by dividing the incidence rate among females by the 
incidence rate among males, and 95% confidence intervals were calculated to determine their 
significance. All incidence rates were age-adjusted using the 2000 US Standard Population. The 
incidence rate ratio calculations were then stratified by age groups (18-49, 50-64, 65-74, 75-84, and 
≥85 years old), race (non-Hispanic white, non-Hispanic black, Hispanic, non-Hispanic Asian, and 
non-Hispanic other), SES group (<5% 5-<10%, 10-<20%, and ≥20%), and FSN site.  
All analyses were repeated to account for pregnancy. In these calculations, pregnant cases 
were excluded from the numerator. For calculations excluding pregnant women from the 
denominator, average percentages of women who were pregnant were estimated by taking the 
number of live births in 2010 measured by the Centers for Disease Control and Prevention’s National 







Overall Trends by Sex and Age 
During two influenza seasons, there were 6,292 laboratory-confirmed influenza-associated 
hospitalizations among adults in 76 counties across 14 FSN sites composed of nearly 21 million 
adults. Of these, 55.5% were female (Table 1). The crude female:male incidence rate ratio (IRR) was 
1.17 (95% CI  1.11-1.22, p<0.0001), but this difference disappeared when age-adjusted (Table 2).  
The relative risk for females compared to males was highest for the youngest age group, 18-
49 year olds with a 32% increased risk compared to males in the same age group (IRR=1.32, 95% CI 
1.20-1.44, p<0.0001, Table 3). This risk was lower in each subsequent age group, ending with the 
lowest IRR among ages ≥85 (IRR=0.67, 95% CI 0.59-0.77, p<0.0001), in which males were at 
increased risk compared to females.  
Sex Differences by SES  
Socioeconomic groups approximated by area-based poverty also demonstrated a clear IRR 
gradient in which risk for females compared to males increased with decreasing SES (Table 4). 
While there was no difference between females’ and males’ incidence rates in census tracts with <5% 
poverty (IRR=0.98, 95% CI 0.88-1.10, p=0.78), when age-adjusted, the IRR indicated that females 
were significantly less likely to be hospitalized than males (aIRR=0.83, 95% CI 0.72-0.95, 
p=0.0017). Even though age-adjusted IRRs increased as SES decreased, no low SES group had an 
aIRR that was significantly greater than 1.  
Sex Differences by Race 
 
Analysis of crude IRRs indicated that non-Hispanic white, non-Hispanic black, and Hispanic 
females were statistically more likely to be hospitalized than their male counterparts (Table 5). When 
adjusted for age, the risk of hospitalization shifted sharply among non-Hispanic whites, and females 
were less likely to be hospitalized than males (aIRR=0.91, 95% CI 0.85-0.98, p=0.0091). The only 
group in which females remained at higher risk than males was among Hispanic women (aIRR=1.25, 
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95% CI 1.06-1.44, p=0.0208). When Hispanic females were stratified by age, only 18-49 year old 




When adjusted for pregnancy, the overall age-adjusted IRR lowered from 1.00 to 0.92 (95% 
CI 0.87-0.97, p=0.0019), indicating that non-pregnant females overall were significantly less likely to 
be hospitalized than males for influenza-associated infections during 2010-2012 (data not shown). 
This trend remained during age stratifications; females ages 18-49 had previously been at higher risk 
than their male counterparts, but when adjusted for pregnancy, the IRR lowered to 1.03 (95% CI 
0.94-1.14, p=0.53, Table 7).  
Pregnancy fully accounted for the increased risk among Hispanic females ages 18-49 that 
were at significantly greater risk than males, as adjusting for pregnancy lowered the IRR from 1.70 to 
1.11 (95% CI 0.85-1.46, p=0.43, Table 7). When adjusted for pregnancy, the age-adjusted IRR 
among all Hispanic females similarly lowered from 1.25 to 1.12 (95% CI 0.92-1.32, p=0.26, data not 
shown).  
No SES group showed significant differences between females and males ages 18-49 once 
adjusted for pregnancy (Table 7). However, within this age category the highest SES groups had 
IRRs less than 1, indicating females were less likely to be hospitalized than males, while the lowest 
SES groups had IRRs greater than 1, indicating females were more likely to be hospitalized than 
males. In the lowest SES group (≥20% poverty), when adjusted for pregnancy, females ages 18-49 
were on the margin of being statistically more likely to be hospitalized than males (IRR 1.15, 95% 
0.98-1.35, p=0.08).  
Geographic Sites 
 
Of the 14 sites, 12 had crude female:male IRRs greater than 1 and 7 of those were 
statistically significant (Table 8). Of those 12, they ranged from 1.08 (95% CI 0.85-1.38, p=0.53) in 
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New Mexico to 1.46 (95% CI 1.08-1.98, p=0.0134) in Tennessee. The two sites with crude IRRs less 
than 1 were New York and Michigan. After age adjustment, no site had a statistically significant IRR 
>1 and one site, New York, had a statistically significant IRR that was less than 1, showing that 
females were less likely to be hospitalized than males (aIRR 0.81, 95% CI 0.63-0.98, p=0.0176). The 
point estimate of the IRRs for all sites was less than 1 for persons ≥85 years old.  
Vaccine Coverage  
Seasonal vaccine coverage rates among adult cases were similar, as 48.1% of females and 
49.9% of males were vaccinated in the season of their hospital admission (Table 9). When stratified 
by age, both sexes exhibited a clear gradient where older age categories were more likely to be 
vaccinated. There were no differences by age group except among cases ages ≥85 years old, in which 
female cases were less likely to be vaccinated than males (68.4% vs 78.3%, p=0.0013). Among 
pregnant women ages 18-49, 25.2% were vaccinated compared to 27.8% of their non-pregnant 








In this analysis females overall were not at greater risk for influenza-associated 
hospitalization than males, even though 55.5% of the cases were female. In fact, certain categories of 
males—including non-Hispanic whites, those living in census tracts with <5% poverty, and persons 
≥85 years old—were at greater risks than females. These differences do not appear to be fully 
explained by vaccine coverage. The only group of females at significantly higher risk than males 
were Hispanic women, particularly those ages 18-49, but this increased risk was fully accounted for 
by pregnancy.  
Sex differences were largely consistent across US sites. Of the 14 sites, 12 had crude IRRs 
greater than 1, but after age-adjustment no site had an IRR that was significantly greater than 1. New 
York had a statistically significant aIRR less than 1, indicating that females were less likely to be 
hospitalized than males. This has important implications for the consistency of these findings across 
the US, as this is one of the few studies to examine sex differences across a large geographic area 
during the same influenza seasons with similar data collection and analysis methodology. 
Interestingly, females ≥85 years old were consistently at lower risk than their male 
counterparts for hospitalization. This finding was consistent across SES group but not race. There is 
no clear implication to this finding, as there has been a long-standing recommendation for annual 
influenza vaccination for all persons ≥65 years old. Furthermore, the increased IRR for males is not 
accounted for by vaccination status; in fact, males ≥85 have significantly higher vaccination rates 
than their female counterparts (p=0.0013). Further studies should explore the possibility of 
underlying co-morbidities as drivers of this sex difference.  
Notably, only 25.5% of pregnant females were vaccinated, a rate that was 2.3% lower than 
their age-matched non-pregnant counterparts. These findings reinforce vaccine policy 
recommendations for focused efforts targeting pregnant women (13) given their relatively low 
vaccination rates compared to older age groups. There are two important reasons to vaccinate 
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pregnant women: first, they are at higher risk of complications and severe illness when they get 
influenza (13) and secondly, they provide passive immunity to protect their future infant (14). 
Recommendations that specifically encourage vaccination of pregnant women began in 2004, but it 
is unclear if there is any comprehensive routine monitoring of vaccination rates among pregnant 
women. Estimations conducted by the CDC through an annual Internet Panel Survey suggest 
approximately 50% of pregnant women were vaccinated in the past influenza season (15), but more 
robust surveillance systems are necessary to accurately measured vaccine uptake in this vulnerable 
target group.  
This study’s findings contrast with a previous study conducted at the EIP, but there are 
several differences (4). First, the former EIP study only analyzed data from one site, Connecticut. 
However, when broken into site-specific analyses, this project did not show significant differences 
between females and males in Connecticut when age-adjusted. Thus, a more important difference 
may be that this analysis only covered two years of influenza-associated hospitalization surveillance 
in which H3N2 was the predominant strain. The former study covered four years of influenza-
associated hospitalizations, including the 2009 pandemic H1N1 strain, which tended to affect 
younger age groups and had been shown to have worse morbidity and hospitalization rates for 
females (1). Additional contrasts with other studies include this study’s stratifications by age, race, 
and SES, as well as adjustments for pregnancy. 
Limitations 
The data examined is limited to laboratory-confirmed cases of influenza and some patients 
may not be tested for influenza or may falsely test negative, although this is unlikely to be sex-
specific. Additionally, conclusions cannot be extrapolated beyond hospitalization to true influenza 
incidence or mortality patterns in the population, as hospitalization patterns may reflect other issues 
(such as SES). However, sex differences in the patterns of influenza-associated hospitalizations 
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themselves are of public health significance as they are costly in addition to being indicators of 
serious illness.  
Additionally, analyses covered two flu seasons, 2010-2011 and 2011-2012, which may not be 
representative years of influenza hospitalization patterns. Analyses from different years are needed to 
determine the consistency of these findings. This is especially important given that the circulating 
strain in any given year may affect sex differences, especially if there is little existing immunity in 
the population. 
Finally, the effect of pregnancy on influenza-associated hospitalizations was estimated given 
the number of live births in 2010 compared to the number of females in the 2010 Census. These 
estimations may not accurately represent the effect of pregnancy on influenza-associated 
hospitalizations, although they are conservative estimates that only subtracted pregnancies that 
resulted in live births. 
Strengths  
 This is the first study to assess sex differences in influenza-associated hospitalizations across 
a large geographic area with many cases. Additionally, this is one of the few studies to examine the 
relationship between sex, age, and influenza-associated hospitalizations along with additional 
demographic factors including race and SES, and adjustment for pregnancy. Finally, vaccination 
status was analyzed for those hospitalized, allowing direct comparisons between different groups of 
cases to be made.   
Future Studies 
Studies covering sex differences in influenza-associated hospitalizations by age over a long 
period of time are necessary to establish the stability of these patterns. Drivers for these differences 
should be explored more fully, including more specific vaccine coverage among the different risk 
groups analyzed and co-morbidities among cases. Sex differences in influenza-associated 
hospitalizations should also be compared to sex differences in influenza-associated mortalities to 
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determine if survival outcomes are similar for females and males. Finally, monitoring influenza 
vaccination rates for pregnant women should be strengthened to effectively evaluate efforts to 
improve vaccination levels among this group. 
Conclusions 
Despite mixed evidence, reports from the WHO have noted that influenza morbidity and 
mortality is overall worse for females, although there is currently no verdict on sex differences in 
influenza-associated hospitalizations (1). This study provides new evidence that in the United States 
in 2010-2012, there was not an important sex difference in influenza-associated hospitalizations other 
than increased rates of hospitalizations among pregnant women. The fact that the greatest risks to 
females were pregnancy-associated reinforces vaccine policy targeting pregnant women and suggests 





Table 1. Characteristics of adult cases with influenza-associated hospitalizations, 2010-2012 
 Cases (n=6,292) %* 
Sex   
   Female  3,493 55.5% 
   Male 2,799 44.5% 
Age   
   18-49 1,897 30.1% 
   50-64 1,498 23.8% 
   65-74 899 14.3% 
   75-84 1,026 16.3% 
   ≥85 972 15.4% 






Table 2. Average annual incidence rate and incidence rate ratio of influenza-associated 









95% CI p-value 
Incidence 6,292 15.05 --- --- --- --- --- --- 
   Female  3,493 16.16 1.17 1.11, 1.22 <0.0001 1.00 0.94, 1.05 0.85 
   Male 2,799 13.86 Ref --- --- Ref --- --- 






Table 3. Average annual incidence rate and incidence rate ratio of influenza-associated 
hospitalizations by age and sex, 2010-2012 
 Cases Incidence rate† IRR 95% CI p-value 
Ages 18-49 1,897 7.51 --- --- --- 
   Female 1,083 8.53 1.32 1.20, 1.44 <0.0001 
   Male 814 6.48 Ref --- --- 
Ages 50-64 1,498 14.52 --- --- --- 
   Female  793 14.87 1.05 0.957, 1.65 0.33 
   Male 705 14.13 Ref --- --- 
Ages 65-74 899 26.74 --- --- --- 
   Female  473 26.07 0.95 0.83, 1.08 0.42 
   Male 426 27.53 Ref --- --- 
Ages 75-84 1,026 51.76 --- --- --- 
   Female  570 48.85 0.87 0.77, 0.99 0.0312 
   Male 456 55.93 Ref --- --- 
Ages ≥85 972 108.46 --- --- --- 
   Female  574 93.95 0.67 0.59, 0.77 <0.0001 
   Male 398 139.53 Ref --- --- 





Table 4. Average annual incidence rate and incidence rate ratio of influenza-associated 











95% CI p-value 
<5% poverty  1,239 11.77 --- --- --- --- --- --- 
   Female  636 11.68 0.98 0.88, 1.10 0.78 0.83 0.72, 0.95 0.0017 
   Male  603 11.86 Ref --- --- --- --- --- 
5-<10% poverty 1,434 13.31 --- --- --- --- --- --- 
   Female  804 14.32 1.17 1.06, 1.30 0.0027 0.99 0.88, 1.09 0.79 
   Male   630 12.21 Ref --- --- --- --- --- 
10-<20% poverty 1,735 15.40 --- --- --- --- --- --- 
   Female   980 16.72 1.20 1.09, 1.32 0.0002 1.02 0.92, 1.11 0.72 
   Male   755 13.97 Ref --- --- --- --- --- 
≥20% poverty 1,880 20.54 --- --- --- --- --- --- 
   Female   1,072 22.93 1.27 1.16, 1.39 <0.0001 1.08 0.98, 1.17 0.12 
   Male  808 18.05 Ref --- --- --- --- --- 
*There are 4 (0.06%) missing cases and 43,463 (0.2%) persons in the population with missing socioeconomic status 
data.  








Table 5. Average annual incidence rate and incidence rate ratio of influenza-associated 










95% CI p-value 
White  3,554 12.99 --- --- --- --- --- --- 
     Female  1,907 13.53 1.09 1.02, 1.16 0.0099 0.91 0.85, 0.98 0.0091 
     Male  1,647 12.41 Ref --- --- Ref --- --- 
Black 1,254 21.97 --- --- --- --- --- --- 
     Female 740 23.90 1.21 1.09, 1.36 0.0007 1.08 0.96, 1.2 0.22 
     Male 514 19.68 Ref --- --- Ref --- --- 
Hispanic 597 12.32 --- --- --- --- --- --- 
     Female 357 15.08 1.56 1.32, 1.83 <0.0001 1.25 1.06, 1.44 0.0208 
     Male 240 9.69 Ref --- --- Ref --- --- 
Asian 298 10.49 --- --- --- --- --- --- 
     Female 157 10.41 0.98 0.78, 1.24 0.89 0.85 0.61, 1.08 0.17 
     Male 141 10.58 Ref --- --- Ref --- --- 
Other 76 7.25 --- --- --- --- --- --- 
     Female  42 7.59 1.11 0.70, 1.74 0.66 0.96 0.43, 1.48 0.87 
     Male 34 6.86 Ref ---   --- Ref ---   --- 
*There are 513 (8.2%) cases with missing race.   






Table 6. Average annual incidence rate and incidence rate ratio of influenza-associated 
hospitalizations among adults by sex among Hispanics, 2010-2012 
 Cases  Incidence rate† IRR  95% CI p-value 
Ages 18-49 278 7.43 --- --- --- 
     Female 169 9.48 1.70 1.34, 2.17 <0.0001 
     Male 109 5.56 Ref --- --- 
Ages 50-64 139 18.34 --- --- --- 
     Female 78 20.12 1.22 0.87, 1.71 0.24 
     Males 61 16.47 Ref --- --- 
Ages 65-74 83 40.36 --- --- --- 
     Females 50 44.21 1.24 0.80, 1.92 0.34 
     Males 33 35.66 Ref --- --- 
Ages 75-84 55 51.78 --- --- --- 
     Females 34 54.42 1.13 0.66, 1.95 0.65 
     Males 21 48.01 Ref --- --- 
Ages ≥85 42 122.46 --- --- --- 
     Females 26 115.73 0.86 0.46, 1.60 0.62 
     Males 16 135.23 Ref --- --- 








Table 7. Average annual incidence rate and incidence rate ratio of influenza-associated 
hospitalizations among adults adjusted for pregnancy, 2010-2012 
 Cases  Incidence rate† IRR  95% CI p-value 
Overall Ages 18-49 1,615 6.59 --- --- --- 
     Female 801 6.69 1.03 0.94, 1.14 0.53 
     Male 814 6.48 Ref --- --- 
      
White Ages 18-49 699 4.78 --- --- --- 
     Female 333 4.70 0.97 0.83, 1.12 0.65 
     Male 366 4.86 Ref --- --- 
Black Ages 18-49 488 13.22 --- --- --- 
     Female 252 13.24 1.00 0.84, 1.20 0.97 
     Males 236 13.20 Ref --- --- 
Hispanic Ages 18-49 211 5.86 --- --- --- 
     Females 102 6.20 1.11 0.85, 1.46 0.43 
     Males 109 5.56 Ref --- --- 
Asian Ages 18-49 59 3.15 --- --- --- 
     Females 25 2.59 0.69 0.41, 1.16 0.17 
     Males 34 3.73 Ref --- --- 
Other Ages 18-49 29 3.74 --- --- --- 
     Females 15 3.71 0.98 0.47, 2.04 0.96 
     Males 14 3.77 Ref --- --- 
      
<5% Poverty Ages 18-49 222 3.96 --- --- --- 
     Female 102 3.68 0.87 0.67, 1.14 0.31 
     Males 120 4.22 Ref --- --- 
5-<10% Poverty Ages 18-49 312 5.17 --- --- --- 
     Females 143 4.81 0.87 0.70, 1.09 0.23 
     Males 169 5.52 Ref --- --- 
10-<20% Poverty Ages 18-49 455 6.74 --- --- --- 
     Females 233 7.06 1.10 0.91, 1.32 0.33 
     Males 222 6.44 Ref --- --- 
≥20 Poverty Ages 18-49 622 10.28 --- --- --- 
     Females 321 11.04 1.15 0.98, 1.35 0.08 
     Males 301 9.58 Ref --- --- 















95% CI p-value 
California 866 16.30 --- --- --- --- --- --- 
     Female 476 17.53 1.17 1.02, 1.33 0.0237 0.98 0.84, 1.11 0.73 
    Male 390 15.02 Ref --- --- Ref --- --- 
Colorado 619 16.95 --- --- --- --- --- --- 
     Female 332 17.90 1.12 0.96, 1.31 0.16 0.91 0.75, 1.08 0.28 
    Male 287 15.98 Ref --- --- Ref --- --- 
Connecticut  726 24.36 --- --- --- --- --- --- 
     Female 419 26.76 1.23 1.06, 1.43 0.0053 1.05 0.90, 1.20 0.55 
    Male 307 21.70 Ref --- --- Ref --- --- 
Georgia 558 10.25 --- --- --- --- --- --- 
     Female 317 11.12 1.20 1.01, 1.42 0.0347 1.00 0.83, 1.18 0.97 
    Male 241 9.29 Ref --- --- Ref --- --- 
Maryland 624 15.21 --- --- --- --- --- --- 
     Female 358 16.55 1.21 1.03, 1.41 0.0205 1.08 0.92, 1.24 0.34 
    Male 266 13.72 Ref --- --- Ref --- --- 
Michigan   57 7.88 --- --- --- --- --- --- 
     Female 29 7.72 0.96 0.57, 1.61 0.88 0.85 0.32, 1.37 0.53 
    Male 28 8.05 Ref --- --- Ref --- --- 
Minnesota 498 11.59 --- --- --- --- --- --- 
     Female 271 12.27 1.13 0.95, 1.35 0.18 0.94 0.75, 1.12 0.47 
    Male 227 10.87 Ref --- --- Ref --- --- 
New Mexico 258 13.55 --- --- --- --- --- --- 
     Female 138 14.07 1.08 0.85, 1.38 0.53 0.94 0.69, 1.19 0.62 
    Male 120 13.00 Ref --- --- Ref --- --- 
New York 527 15.55 --- --- --- --- --- --- 
     Female 265 15.09 0.94 0.79, 1.12 0.49 0.81 0.63, 0.98 0.0176 
    Male 262 16.04 Ref --- --- Ref --- --- 
Ohio 369 13.35 --- --- --- --- --- --- 
     Female 198 13.89 1.09 0.89, 1.33 0.43 1.02 0.81, 1.23 0.84 
    Male 171 12.78 Ref --- --- Ref --- --- 
Oregon 375 14.82 --- --- --- --- --- --- 
     Female 225 17.34 1.43 1.16, 1.75 0.0008 1.20 0.98, 1.41 0.10 
    Male 150 12.16 Ref --- --- Ref --- --- 
Rhode Island 233 23.82 --- --- --- --- --- --- 
     Female 138 26.84 1.31 1.01, 1.70 0.0424 1.11 0.85, 1.38 0.44 
    Male 95 20.48 Ref --- --- Ref --- --- 
Tennessee 178 7.84 --- --- --- --- --- --- 
     Female 109 9.25 1.46 1.08, 1.98 0.0134 1.31 0.99, 1.62 0.10 
     Male 69 6.32 Ref --- --- Ref --- --- 
Utah 404 27.68 --- --- --- --- --- --- 
     Female 218 29.82 1.17 0.96, 1.42 0.12 1.01 0.81, 1.21 0.95 
     Male 186 25.53 Ref --- --- Ref --- --- 







Table 9: Vaccine coverage among influenza-associated hospitalizations by sex and age, 2010-
2012 
 Females Vaccinated (n=3,135)* Males Vaccinated (n=2,483)* p-value** 
Total 1,507 (48.1%) 1,240 (49.9%) 0.16 
     Ages 18-49 256 (27.2%) 181 (25.6%) 0.46 
     Ages 50-64 289 (40.5%) 270 (43.8%) 0.23 
     Ages 65-74 269 (61.0%) 230 (58.8%) 0.52 
     Ages 75-84 345 (65.0%) 284 (68.1%) 0.31 
     Ages ≥ 85 348 (68.4%) 275 (78.3%) 0.0013 
*There were 358 (10.2%) females and 316 (11.3%) males with missing vaccination status.  





Table 10: Vaccine coverage among female influenza-associated hospitalizations ages 18-49 by 
pregnancy status, 2010-2012 
 Pregnant Females Vaccinated  Non-Pregnant Females Vaccinated p-value** 
Total* 63 (25.5%) 193 (27.8%) 0.48 
     Ages 18-24 25 (25.3%) 26 (24.3%) 0.87 
     Ages 25-29 11 (14.9%) 30 (28.0%) 0.0374 
     Ages 30-34 15 (35.7%) 26 (26.0%) 0.24 
     Ages 35-39 11 (44.0%) 26 (24.1%) 0.0451 
     Ages 40-44 1 (14.3%) 37 (30.3%) 0.33** 
     Ages 45-49 n/a 48 (32.0%) n/a 
*There were 142 (13.1%) females ages 18-49 with missing vaccination status.  
**P-values were calculated by χ2 for age groups 18-24, 25-29, 30-34, and 35-39. A Fisher’s exact test was 
used for ages 40-44 due to low counts in this group, and no tests were run for ages 45-49 because there 
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